Dr. Michael Alan Weitz, MD

Dr. Weitz practices at Miami Sunset Surgery Center,LLC in Miami, Florida.

Dr. Weitz's NPI, 1639145337, was assigned on February 23, 2006. Dr. Weitz graduated from Weill Cornell Medicine in 1974. Dr. Weitz holds Florida license ME0029165.

Dr. Weitz's primary practice is Miami Sunset Surgery Center,LLC, at 7190 Sw 87th Ave, Miami, FL 33173 in Miami-Dade County. The practice phone is (305) 596-2228.

Dr. Weitz's primary practice is Miami Sunset Surgery Center,LLC in Miami, Florida. Dr. Weitz is also affiliated with Baptist Health Baptist Hospital. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Weitz to 3 more hospitals, 1 group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weitz practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Weitz's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Weitz's licenses on file in 3 states: Florida, Maryland and Washington.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Weitz treats.

CMS data shows 182,859 Medicare services from Dr. Weitz across 53 procedure codes in 2024, for 970 Medicare patients. Medicare paid $2,374,021 for them. Every service was in an office.

CMS counts 970 Medicare patients who saw Dr. Weitz in 2024. The largest group is 65 to 74, with 421 patients. 75% of them have arthritis, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Weitz's median patient age at 67, with 80% women.

In 2024, Dr. Weitz wrote 2,574 Medicare Part D claims for 528 patients. 85% of them were for generic drugs. CMS names the drug for 2,194 of them, across 49 drugs with 11 or more claims each, at $769,804 in total drug cost. In 2023, CMS named 2,302 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Weitz for performance year 2024, reported as part of a group. Dr. Weitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weitz as offering telehealth.

Dmand AI links 2 papers to Dr. Weitz, published from 2013 to 2016. Dr. Weitz's most frequent co-authors are Daniel F. Kelly, MD and Anthony I. Sebba, MD.

Dmand AI links Dr. Weitz to 2 clinical trials. Conditions studied include Osteoporosis, Postmenopausal, Spondylitis, Ankylosing and Axial Spondyloarthritis.

CMS Open Payments shows 2,590 general payments to Dr. Weitz from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Amgen Inc. paid the most, $440,005.

Dmand AI lists 5 awards for Dr. Weitz, most recently Top Doctors:South Florida in 2012.

Dr. Weitz graduated from Weill Cornell Medicine in 1974. Dr. Weitz is a member of ACP and ACR.

Dr. Weitz is in network with 16 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.